TNF and prostate cancer: In several studies, it has also been reported that serum TNF concentration is increased in different cancer patients; moreover, its concentration was markedly decreased during chemotherapy in breast [81] and prostate cancer patients [82], correlating well with response to treatment, suggesting that serum TNF levels could be a potential predictive biomarker in these cancer types.